The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Obrien Christopher Flint since 2008.
The trader's CIK number is 1343124.
At the time of the last reporting, Obrien Christopher Flint was the Sr. VP & Chief Medic of Neurocrine Biosciences Inc. (stock ticker symbol NBIX).
Also see all insider trading activities at Neurocrine Biosciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | NBIX | 0 | $0 | 4,363 | $355,912 | 0 | $0 |
| 2017 | NBIX | 0 | $0 | 246,198 | $14,137,237 | 226,927 | $1,760,575 |
| 2016 | NBIX | 0 | $0 | 105,000 | $5,021,424 | 0 | $0 |
| 2015 | NBIX | 0 | $0 | 124,750 | $4,787,049 | 96,250 | $380,050 |
| 2014 | NBIX | 0 | $0 | 111,750 | $2,334,765 | 60,000 | $155,399 |
| 2013 | NBIX | 0 | $0 | 62,500 | $831,390 | 0 | $0 |
| 2011 | NBIX | 0 | $0 | 12,320 | $84,096 | 0 | $0 |
| 2010 | NBIX | 0 | $0 | 14,993 | $38,084 | 0 | $0 |
| 2009 | NBIX | 0 | $0 | 18,472 | $61,774 | 0 | $0 |
| 2008 | NBIX | 0 | $0 | 4,824 | $22,624 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-02-05 | NBIX | Sale | 2,613 | 83.20 | 217,414 |
| 2018-01-16 | NBIX | Sale | 1,750 | 79.14 | 138,498 |
| 2017-11-02 | NBIX | Option Ex | 52,817 | 8.65 | 457,131 |
| 2017-11-02 | NBIX | Sale | 52,817 | 69.71 | 3,681,661 |
| 2017-10-02 | NBIX | Option Ex | 6,925 | 8.65 | 59,901 |
| 2017-10-02 | NBIX | Sale | 6,925 | 61.04 | 422,702 |
| 2017-09-05 | NBIX | Option Ex | 52,817 | 8.66 | 457,395 |
| 2017-09-05 | NBIX | Sale | 52,817 | 57.50 | 3,036,977 |
| 2017-07-27 | NBIX | Sale | 8,734 | 50.00 | 436,700 |
| 2017-07-27 | NBIX | Option Ex | 8,734 | 8.65 | 75,549 |
| 2017-05-18 | NBIX | Option Ex | 105,634 | 6.73 | 710,599 |
| 2017-05-18 | NBIX | Sale | 105,634 | 53.32 | 5,632,404 |
| 2017-04-12 | NBIX | Sale | 13,065 | 50.82 | 663,963 |
| 2017-02-06 | NBIX | Sale | 1,206 | 43.17 | 52,063 |
| 2017-02-03 | NBIX | Sale | 1,500 | 42.50 | 63,750 |
| 2017-01-17 | NBIX | Sale | 1,750 | 40.66 | 71,155 |
| 2017-01-10 | NBIX | Sale | 1,750 | 43.35 | 75,862 |
| 2016-11-15 | NBIX | Sale | 25,000 | 52.84 | 1,321,000 |
| 2016-08-15 | NBIX | Sale | 12,500 | 48.73 | 609,125 |
| 2016-05-31 | NBIX | Sale | 12,500 | 50.00 | 625,000 |
| 2016-05-16 | NBIX | Sale | 25,000 | 45.00 | 1,125,000 |
| 2016-04-06 | NBIX | Sale | 25,000 | 45.00 | 1,125,000 |
| 2016-02-03 | NBIX | Sale | 1,500 | 38.01 | 57,015 |
| 2016-01-19 | NBIX | Sale | 1,750 | 46.77 | 81,847 |
| 2016-01-11 | NBIX | Sale | 1,750 | 44.25 | 77,437 |
| 2015-10-16 | NBIX | Sale | 25,000 | 47.78 | 1,194,500 |
| 2015-07-20 | NBIX | Option Ex | 11,250 | 5.76 | 64,800 |
| 2015-07-20 | NBIX | Sale | 11,250 | 55.00 | 618,750 |
| 2015-07-13 | NBIX | Option Ex | 10,000 | 5.76 | 57,600 |
| 2015-07-13 | NBIX | Sale | 10,000 | 50.00 | 500,000 |
| 2015-06-08 | NBIX | Option Ex | 10,000 | 5.76 | 57,600 |
| 2015-06-08 | NBIX | Sale | 10,000 | 45.00 | 450,000 |
| 2015-06-01 | NBIX | Sale | 10,000 | 42.20 | 422,000 |
| 2015-06-01 | NBIX | Option Ex | 10,000 | 5.76 | 57,600 |
| 2015-01-16 | NBIX | Sale | 1,750 | 30.79 | 53,882 |
| 2015-01-12 | NBIX | Sale | 1,750 | 28.41 | 49,717 |
| 2015-01-08 | NBIX | Option Ex | 55,000 | 2.59 | 142,450 |
| 2015-01-08 | NBIX | Sale | 55,000 | 27.24 | 1,498,200 |
| 2014-12-19 | NBIX | Option Ex | 20,000 | 2.59 | 51,800 |
| 2014-12-19 | NBIX | Sale | 20,000 | 24.02 | 480,400 |
| 2014-12-10 | NBIX | Option Ex | 20,125 | 2.59 | 52,123 |
| 2014-12-11 | NBIX | Option Ex | 19,875 | 2.59 | 51,476 |
| 2014-12-10 | NBIX | Sale | 20,125 | 21.77 | 438,221 |
| 2014-12-11 | NBIX | Sale | 19,875 | 22.10 | 439,237 |
| 2014-11-24 | NBIX | Sale | 5,463 | 19.53 | 106,692 |
| 2014-11-17 | NBIX | Sale | 11,300 | 19.51 | 220,463 |
| 2014-11-13 | NBIX | Sale | 3,237 | 19.50 | 63,121 |
| 2014-11-10 | NBIX | Sale | 20,000 | 18.62 | 372,400 |
| 2014-01-10 | NBIX | Sale | 6,750 | 18.77 | 126,731 |
| 2014-01-07 | NBIX | Sale | 5,000 | 17.50 | 87,500 |
| 2013-09-03 | NBIX | Sale | 5,000 | 16.00 | 80,000 |
| 2013-08-05 | NBIX | Sale | 5,000 | 15.00 | 75,000 |
| 2013-07-12 | NBIX | Sale | 5,000 | 14.50 | 72,500 |
| 2013-06-27 | NBIX | Sale | 3,857 | 13.00 | 50,141 |
| 2013-06-28 | NBIX | Sale | 7,500 | 13.50 | 101,250 |
| 2013-06-20 | NBIX | Sale | 21,217 | 12.39 | 262,984 |
| 2013-06-21 | NBIX | Sale | 14,926 | 12.70 | 189,515 |
| 2011-02-28 | NBIX | Sale | 12,320 | 6.83 | 84,096 |
| 2010-03-01 | NBIX | Sale | 13,490 | 2.53 | 34,102 |
| 2010-01-04 | NBIX | Sale | 1,503 | 2.65 | 3,982 |
| 2009-09-28 | NBIX | Sale | 4,859 | 3.11 | 15,130 |
| 2009-03-30 | NBIX | Sale | 12,151 | 3.43 | 41,653 |
| 2009-01-05 | NBIX | Sale | 1,462 | 3.41 | 4,991 |
| 2008-09-29 | NBIX | Sale | 4,824 | 4.69 | 22,624 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Obrien Christopher Flint (Sr. VP & Chief Medic of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.